MicroVue™ TRAP5b EIA
The MicroVue TRAP5b Assay is an immunocapture enzyme assay for the determination of tartrate-resistant acid phosphatase isoform 5b (TRAcP 5b) in human serum and plasma.
Product Specifications
| Citations | 11 |
|---|---|
| Specimen | Serum/Heparin Plasma 50 μL |
| LLOQ | N/A |
| ULOQ | N/A |
| Assay Time | 2 hours |
| Cross Reactivity | None |
Ordering Information
| Catalog Number | 8033 |
|---|---|
| Catalog Number (CE) | 8036 |
| Size | 96 wells/test |
| Price (USD) | $970.00 |
| Price (EURO) | 680,00 € |
Contact us
| US Phone | +1 (858) 552 1100 |
|---|---|
| EU Phone | +353 (91) 412 474 |
| US Email | contact-us@quidelortho.com |
| EU Email | contact-emea@quidelortho.com |
- Specifications
- Citations
- Certificate of Analysis
Specifications
| Description | The MicroVue TRAP5b Assay is an immunocapture enzyme assay for the determination of tartrate-resistant acid phosphatase isoform 5b (TRAcP 5b) in human serum and plasma. |
|---|---|
| Size | 96 wells/test |
| Form | 96 well plate with murine monoclonal anti-TRAP5b antibodies |
| Specimen | Serum/Heparin Plasma 50 μL |
| Limit of Detection (LOD) | 0.24 U/L |
| Lower Limit of Quantitation (LLOQ) | N/A |
| Upper Limit of Quantitation (ULOQ) | N/A |
| Intra Assay | 1.9–2.2% |
| Inter Assay | 2.0–3.0% |
| Standards | 5 |
| Controls | 2 |
| Sample Values | Females (Ages 30–44) (premenopausal) 2.9±1.4 U/L or (Ages ≥50) (postmenopausal) 4.3±1.5 U/L, Males (Ages ≥20) 4.0±1.4 U/L |
| Assay Time | 2 hours |
| Cross Reactivity | None |
| Storage | Store unopened kit between 2°C to 8°C. Refer to manual for storing individual components |
| Background | TRAP5b (serum band 5 tartrate-resistant acid phosphatase, TRAcP 5b; EC 3.1.3.2) is a 35-37 kDa glycoprotein. TRAP5b is typically expressed in proportion to osteoclast activity and is secreted into circulation. As a result, serum TRAP5b is considered a potentially useful marker for bone resorption. The MicroVue TRAP5b EIA detects the enzyme activity of bound TRAP5b in experimental samples. |
Citations
| Title | Year | Applications | Sample Species | Sample | Sample Details |
|---|---|---|---|---|---|
Clinical and Biological Signature of Osteochondritis Dissecans in a Cross-Sectional Study. | 2019 | ELISA | Human | Serum | Osteochondritis Dissecans |
| 2019 | ELISA | Human | Serum | Chronic Kidney Disease | |
| 2019 | ELISA | Human | Serum | Albers- Schönberg disease | |
| 2019 | ELISA | Human | Serum | N/A | |
Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. | 2017 | ELISA | Human | Serum | N/A |
| 2015 | ELISA | Human | Serum | Premenopausal Women w/wo Type 1 Diabetes | |
| 2015 | ELISA | Human | Serum | Middle-Aged Premenopausal Women | |
| 2013 | ELISA | Human | Monocytes | N/A | |
| 2012 | ELISA | Human | Multiple Myeloma cells | N/A | |
| 2012 | ELISA | Human | Serum | N/A | |
| 2011 | ELISA | Mouse | Serum | N/A |
Certificate of Analysis
